?廣州領(lǐng)晟醫(yī)療科技有限公司，Link Health Group（以下簡稱“領(lǐng)晟醫(yī)藥”）成立于2012年，坐落于廣州市蘿崗區(qū)科學(xué)城，是一家新型醫(yī)藥研發(fā)企業(yè)，專注于新靶點(diǎn)創(chuàng)新藥的開發(fā)。通過我們的不斷努力， 目前領(lǐng)晟醫(yī)藥已完成多層項(xiàng)目儲(chǔ)備，覆蓋臨床前到臨床階段多個(gè)新藥品種。主要集中在腫瘤，骨科，消化科、炎癥以及疫苗等領(lǐng)域。我們的業(yè)務(wù)包括與跨國醫(yī)藥公司、海外專業(yè)醫(yī)藥公司、研發(fā)機(jī)構(gòu)等合作，通過專利藥物的授權(quán)引進(jìn)新藥項(xiàng)目，自主研發(fā)新劑型，合作國際多中心臨床試驗(yàn)，通過合資公司，戰(zhàn)略聯(lián)盟等形式進(jìn)行學(xué)術(shù)推廣以及銷售等。領(lǐng)晟醫(yī)療目前在歐美有超過20家合作企業(yè)，我們?nèi)匀徊粩嘣跉W美開拓新合作與新業(yè)務(wù)。作為一家發(fā)展快速的新技術(shù)企業(yè)，具有開拓精神的團(tuán)隊(duì)，優(yōu)質(zhì)的人才是我們領(lǐng)晟發(fā)展的動(dòng)力和基石。我們歡迎有能力有激情，有致從事創(chuàng)新藥物開發(fā)的您加入。公司網(wǎng)站：http_58_//www.healthinlink.com/Link Health is a company located in China to focus on research of innovative medicinal products. Since 2014, Link Health has grown itself a leading company in China for development of first-in-class new drugs. In the last three years, the company has built a pipeline covering 9 class 2 new drugs including both licensing in and self-developed drug candidates. In which, half has been in clinical stage aboard and half will be enter into the IND in China before the end of 2017. Link Health has a very dynamic team to support the registration and the team will be grownup to support the future plan on FDA file and clinical development in both Asia and US.More information, please refer to the website_58_ www.healthinlink.com